| DB ID | MyCo_4326 |
| Title | Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies |
| Year | 2004 |
| PMID | 15378761 |
| Fungal Diseases involved | Candidemia |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Pdc11p |
| Biomarker Full Name | Pdc11p |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Spain |
| Cohort | Four cases of laboratory-confirmed systemic candidiasis (3 males and 1 female; age range, 38–67 years; median age, 53 years) were identified and recruited prospectively among patients undergoing hematological malignancies between June 1998 and May 1999 in the Hematology and Oncology Department at the Salamanca University Hospital, Spain, and followed longitudinally. |
| Cohort No. | 4 |
| Age Group | 38–67 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Bioinformatics analysis |
| Analysis Method | Immunoproteomics Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunoproteomics Analysis |
| Up Regulation Down Regulation | Positive |
| Sequence Data | Prptide sequence: WAGNANELNAGYAADGYAR, Swissprot: P83779ᵉ⁾ |
| External Link | None |
